Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 06 Nov 2024 07:45 CET |
VISTIN PHARMA | Ex dividend NOK 0.50 today | 20103015 Pharmaceuticals | Ex Date |
| 31 Oct 2024 07:40 CET |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter and YTD 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 24 Oct 2024 10:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 17:00 CEST |
VISTIN PHARMA | Responsibility statement for first half year of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 26 Sep 2024 17:27 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 13 Sep 2024 17:10 CEST |
VISTIN PHARMA | Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2024 16:06 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2024 07:40 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2024 10:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Jun 2024 08:05 CEST |
VISTIN PHARMA | Ex dividend NOK 0.50 today | 20103015 Pharmaceuticals | Ex Date |
| 23 May 2024 14:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2024 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2024 12:56 CEST |
VISTIN PHARMA | Disclosure of voting rights at AGM in Vistin Pharma ASA | 20103015 Pharmaceuticals | Total number of voting rights and capital |
| 30 Apr 2024 08:58 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Apr 2024 23:10 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report 2023 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 24 Apr 2024 07:44 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Apr 2024 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Mar 2024 21:59 CET |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 Mar 2024 08:15 CET |
VISTIN PHARMA | Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary) | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2024 10:30 CET |
VISTIN PHARMA | Vistin Pharma ASA: Key information relating to the proposed cash dividend | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2024 07:45 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 09 Feb 2024 10:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jan 2024 08:00 CET |
VISTIN PHARMA | Ex dividend NOK 0.75 today | 20103015 Pharmaceuticals | Ex Date |
| 11 Jan 2024 11:40 CET |
VISTIN PHARMA | Key information relating to the cash dividend to be paid by Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jan 2024 11:35 CET |
VISTIN PHARMA | Vistin Pharma ASA: Dividend of NOK 0.75 per share | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2023 10:21 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Oct 2023 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 25 Oct 2023 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: New CEO appointed | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Oct 2023 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Sep 2023 18:40 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 26 Aug 2023 09:40 CEST |
VISTIN PHARMA | Mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2023 07:35 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2023 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jul 2023 08:30 CEST |
VISTIN PHARMA | Management in Vistin Pharma ASA purchases shares | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 Jul 2023 08:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Results of offer to buy back shares | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Jun 2023 07:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Offer to buy back shares | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 13:57 CEST |
VISTIN PHARMA | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 22 Jun 2023 13:57 CEST |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Jun 2023 15:15 CEST |
VISTIN PHARMA | Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 31 May 2023 12:05 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 30 May 2023 21:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 22 May 2023 14:52 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the Annual General Meeting 2023 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 May 2023 11:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 28 Apr 2023 12:30 CEST |
VISTIN PHARMA | Notice of Annual General Meeting in Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Apr 2023 17:35 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report for 2022 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 27 Apr 2023 07:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 20 Apr 2023 11:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Feb 2023 08:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 10 Feb 2023 10:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2022 conference call | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 14 Dec 2022 14:41 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2022 12:10 CET |
VISTIN PHARMA | Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft | 20103015 Pharmaceuticals | Non-regulatory press releases |